CLDX CELLDEX THERAPEUTICS INC Management Changes 8-K Filing 2024 - Annual Meeting Approval Celldex Therapeutics, Inc. held its Annual Meeting of Stockholders on June 13, 2024, where stockholders approved an amendment to the company's 2021 Omnibus Equity Incentive Plan, increasing the number of shares available for issuance and the non-employee director award limitation.Get access to all SEC 8-K filings of the CELLDEX THERAPEUTICS INC